Significance of psychiatric comorbidity for the outcome of maintenance treatment - A review of the literature

Mental Health and Substance Use: Dual Diagnosis

Volumn 4, Issue 1, 2011, Pages 62-71

  Schafer, Ingo ^a,b   Fischer, Malte ^a   Reimer, Jens ^a,b   Karow, Anne ^a   Haasen, Christian ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

maintenance treatment; methadone buprenorphine; opioid dependence; outcome; psychiatric comorbidity

Indexed keywords

BENZODIAZEPINE; BUPRENORPHINE; CLONAZEPAM; DESIPRAMINE; DIAMORPHINE; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; METHADONE; OLANZAPINE;

ARTICLE; COGNITIVE THERAPY; COMORBIDITY; CORRELATION ANALYSIS; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; HUMAN; INDIVIDUALIZATION; INFORMATION RETRIEVAL; MAINTENANCE THERAPY; MAJOR DEPRESSION; MENTAL DISEASE; OPIATE ADDICTION; OUTCOME ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL PROBLEM; TREATMENT OUTCOME;

EID: 78651347103     PISSN: 17523281     EISSN: 17523273     Source Type: Journal    
DOI: 10.1080/17523281.2011.533452     Document Type: Article

References (52)

1. Alterman, A.I., Rutherford, M.J., Cacciola, J.S., McKay, J.R., & Woody, G.E. (1996). Response to methadone maintenance and counseling in antisocial patients with and without major depression. Journal of Nervous and Mental Disease, 184, 695-702.
2. Brands, B., Blake, J., Marsh, D.C., Sproule, B., Jeyapalan, R., & Li, S. (2008). The impact of benzodiazepine use on methadone maintenance treatment outcomes. Journal of Addictive Disorders, 27, 37-48.
3. Brooner, R.K., Greenfield, L., Schmidt, C.W., & Bigelow, G.E. (1993). Antisocial personality disorder and HIV infection among intravenous drug abusers. American Journal of Psychiatry, 150, 53-58.
4. Brooner, R.K., King, V.L., Kidorf, M., Schmidt, C.W., Jr., & Bigelow, G.E. (1997). Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry, 54, 71-80.
5. Cacciola, J.S., Alterman, A.I., Rutherford, M.J., McKay, J.R., & Mulvaney, F.D. (2001). The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug and Alcohol Dependence, 61, 271-280.
6. Cacciola, J.S., Rutherford, M.J., Alterman, A.I., McKay, J.R., & Snider, E.C. (1996). Personality disorders and treatment outcome in methadone maintenance patients. Journal of Nervous and Mental Disease, 184, 234-239.
7. Callaly, T., Trauer, T., Munro, L., & Whelan, G. (2001). Prevalence of psychiatric disorder in a methadone maintenance population. Australian and New Zealand Journal of Psychiatry, 35, 601-605.
8. Carpenter, K.M., Brooks, A.C., Vosburg, S.K., & Nunes, E.V. (2004). The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial. Drug and Alcohol Dependence, 74, 123-134.
9. Compton, W.M. III, Cottler, L.B., Jacobs, J.L., Ben-Abdallah, A., & Spitznagel, E.L. (2003). The role of psychiatric disorders in predicting drug dependence treatment outcomes. American Journal of Psychiatry, 160, 890-895.
10. Darke, S., Ross, J.,Williamson, A.,Mills, K.L., Havard, A., & Teesson, M. (2007). Borderline personality disorder and persistently elevated levels of risk in 36-month outcomes for the treatment of heroin dependence. Addiction, 102, 1140-1146.
11. Darke, S., Swift, W., & Hall, W. (1994). Prevalence, severity and correlates of psychological morbidity among methadone maintenance clients. Addiction, 89, 211-217. (Pubitemid 24056636)
12. Darke, S.,Williamson, A., Ross, J., Teesson, M., & Lynskey, M. (2004). Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: Findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Dependence, 74, 77-83.
13. Gelkopf, M., Weizman, T., Melamed, Y., Adelson, M., & Bleich, A. (2006). Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic. Israel Journal of Psychiatry and Related Sciences, 43, 126-136.
14. Gerra, G., Borella, F., Zaimovic, A., Moi, G., Bussandri, M., Bubici, C., et al. (2004). Buprenorphine versus methadone for opioid dependence: Predictor variables for treatment outcome. Drug and Alcohol Dependence, 75, 37-45.
15. Gerra, G., Di Petta, G., D'Amore, A., Iannotta, P., Bardicchia, F., Falorni, F., et al. (2007). Combination of olanzapine with opioid-agonists in the treatment of heroin addicted patients affected by comorbid schizophrenia spectrum disorders. Clinical Neuropharmacology, 30, 127-135.
16. Gerra, G., Ferri, M., Polidori, E., Santoro, G., Zaimovic, A., & Sternieri, E. (2003). Longterm methadone maintenance effectiveness: Psychosocial and pharmacological variables. Journal of Substance Abuse Treatment, 25, 1-8.
17. Gerra, G., Leonardi, C., D'Amore, A., Strepparola, G., Fagetti, R., Assi, C., et al. (2006). Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30, 265-272.
18. Gonzalez, G., Feingold, A., Oliveto, A., Gonsai, K., & Kosten, T.R. (2003). Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management. American Journal of Drug and Alcohol Abuse, 29, 497-514.
19. Grella, C.E., Wugalter, S.E., & Anglin, M.D. (1997). Predictors of treatment retention in enhanced and standard methadone maintenance treatment for HIV risk reduction. Journal of Drug Issues, 27, 203-224.
20. Havens, J.R., Latkinm, C.A., Pu, M., Cornelius, L.J., Bishai, D., Huettner, S., et al. (2009). Predictors of opiate agonist treatment retention among injection drug users referred from a needle exchange program. Journal of Substance Abuse Treatment, 36, 306-312.
21. Hien, D.A., Nunes, E., Levin, F.R., & Fraser, D. (2000). Posttraumatic stress disorder and short-term outcome in early methadone treatment. Journal of Substance Abuse Treatment, 19, 31-37.
22. Kamal, F., Flavin, S., Campbell, F., Behan, C., Fagan, J., & Smyth, R. (2007). Factors affecting the outcome of methadone maintenance treatment dependence. Irish Medical Journal, 100, 393-397.
23. King, V.L., Kidorf, M.S., Stoller, K.B., & Brooner, R.K. (2000). Influence of psychiatric comorbidity on HIV risk behaviors: Changes during drug abuse treatment. Journal of Addictive Diseases, 19, 65-83.
24. Kleinman, P.H., Millman, R.B., Robinson, H., Lesser, M., Hsu, C., Engelhart, P., et al. (1994). Lifetime needle sharing: A predictive analysis. Journal of Substance Abuse Treatment, 11, 449-455.
25. Krausz, M., Degkwitz, P., Kü hne, A., & Verthein, U. (1998). Comorbidity of opiate dependence and mental disorders. Addictive Behaviors, 23, 767-783.
26. Lavie, E., Fatseas, M., Denis, C., & Auriacombe, M. (2009). Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence. Drug and Alcohol Dependence, 99, 338-344.
27. Linehan, M.M., Dimeff, L.A., Reynolds, S.K., Comtois, K.A.,Welch, S.S., Heagerty, P., et al. (2002). Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug and Alcohol Dependence, 67, 13-26.
28. Maremmani, I., Pacini, M., Lubrano, S., Perugi, G., Tagliamonte, A., Pani, P.P., et al. (2008). Longterm outcomes of treatment-resistant heroin addicts with and without DSM-IV Axis psychiatric comorbidity (dual diagnosis). European Addiction Research, 14, 134-142.
29. McLellan, A.T., Luborsky, L.,Woody, G.E., O'Brien, C.P., & Druley, K.A. (1983). Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity. Archives of General Psychiatry, 40, 620-625.
30. Musselman, D.L., & Kell, M.J. (1995). Prevalence and improvement in psychopathology in opioid-dependent patients participating in methadone maintenance. Journal of Addictive Disorders, 14, 67-82.
31. Nunes, E.V., Sullivan, M.A., & Levin, F.R. (2004). Treatment of depression in patients with opiate dependence. Biological Psychiatry, 56, 793-802.
32. Nunes, E.V., Quitkin, F.M., Donovan, S.J., Deliyannides, D., Ocepek-Welikson, K., Koeng, T., et al. (1998). Imipramine treatment of opiate-dependent patients with depressive disorders: A placebo controlled trial. Archives of General Psychiatry, 55, 153-160.
33. Pani, P.P., Trogu, E., Contu, P., Agus, A., & Gessa, G.L. (1997). Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program. Drug and Alcohol Dependence, 48, 19-26.
34. Petrakis, I., Carroll, K.M., Nichm, C., Gordon, L., Kosten, T., & Rounsaville, B. (1998). Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts. Drug and Alcohol Dependence, 50, 221-226.
35. Rounsaville, B.J., Kosten, T.R., Weissman, M.M., & Kleber, H.D. (1986). Prognostic significance of psychopathology in treated opiate addicts. Archives of General Psychiatry, 43, 739-745.
36. Rounsaville, B.J., Tierney, T., Crits-Christoph, K., Weissman, M.M., & Kleber, H.D. (1982). Predictors of outcome in treatment of opiate addicts: evidence for the multidimensional nature of addicts' problems. Comprehensive Psychiatry, 23, 462-478.
37. Rounsaville, B.J., Weissman, M.M., Crits-Christoph, K., Wilber, C., & Kleber, H. (1982). Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. Archives of General Psychiatry, 39, 151-156.
38. Rutherford, M.J., Cacciola, J.S., & Alterman, A.I. (1994). Relationships of personality disorders with problem severity in methadone patients. Drug and Alcohol Dependence, 35, 69-76.
39. Schä fer, I., Eiroa, F., Verthein, U., Dilg, C., Haasen, C., & Reimer, J. (2010). Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine and methadone maintenance treatment. Psychopathology, 43, 88-95.
40. Schreiber, S., Peles, E., & Adelson, M. (2008). Association between improvement in depression, reduced benzodiazepine (BDZ) abuse, and increased psychotropic medication use in methadone maintenance treatment (MMT) patients. Drug and Alcohol Dependence, 92, 79-85.
41. Strain, E.C. (2002). Assessment and treatment of comorbid psychiatric disorders in opioiddependent patients. Clinical Journal of Pain, 18, 14-27.
42. Strain, E.C., Brooner, R.K., & Bigelow, G.E. (1991). Clustering a multiple substance use and psychiatric diagnoses in opiate addicts. Drug and Alcohol Dependence, 27, 127-134.
43. Teesson, M., Havard, A., Fairbairn, S., Ross, J., Lynskey, M., & Darke, S. (2005). Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking. Drug and Alcohol Dependence, 78, 309-315. (Pubitemid 40694053)
44. Tourian, K., Alterman, A., Metzger, D., Rutherford, M., Cacciola, J.S., & McKay, J.R. (1997). Validity of three measures of antisociality in predicting HIV risk behaviors in methadone-maintenance patients. Drug and Alcohol Dependence, 47, 99-107.
45. Trafton, J.A., Minkel, J., & Humphreys, K. (2006). Opioid substitution treatment reduces substance use equivalently in patients with and without posttraumatic stress disorder. Journal of Studies on Alcohol and Drugs, 67, 228-235.
46. Verthein, U., Degkwitz, P., Haasen, C., & Krausz, M. (2005). Significance of comorbidity for the long-term course of opiate dependence. European Addiction Research, 11, 15-21.
47. Wedekind, D., Jacobs, S., Karg, I., Luedecke, C., Schneider, U., & Cimander, K., et al. (2008). Psychiatric comorbidity and additional abuse of drugs in maintenance treatment with land d,l-methadone. World Journal of Biological Psychiatry, 29, 1-10.
48. Weizman, T., Gelkopf, M., Melamed, Y., Adelson, M., & Bleich, A. (2003). Treatment of benzodiazepine dependence in methadone maintenance treatment patients: a comparison of two therapeutic modalities and the role of psychiatric comorbidity. Australian and New Zealand Journal of Psychiatry, 37, 458-463.
49. Woody, G.E., Luborsky, L., McLellan, A.T., O'Brien, C.P., Beck, A.T., & Blaine, J., et al. (1983). Psychotherapy for opiate addicts. Archives of General Psychiatry, 40, 636-645.
50. Woody, G.E., McLellan, A.T., Luborsky, L., O'Brien, C.P., Blaine, J., Fox, S., et al. (1984). Severity of psychiatric symptoms as a predictor of benefits of psychotherapy: The VA Penn study. American Journal of Psychiatry, 141, 1172-1177.
51. Woody, G.E., Metzger, D., Navaline, H., McLellan, T., & O'Brien, C.P. (1997). Psychiatric symptoms, risky behavior, and HIV infection. NIDA Research Monograph, 172, 156-170.
52. Zanis, D.A., Metzger, D.S., & McLellan, A.T. (1994). Factors associated with employment among methadone patients. Journal of Substance Abuse Treatment, 11, 443-447.